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In recent years, porcine dendritic cells (DCs) have been identified from pig tissues.
However, studying the interaction of porcine DCs with pathogens is still difficult
due to the scarcity of DCs in tissues. In the present work, the Flt3-ligand (Flt3L)-
based in vitro derivation system was further characterized and compared with
other cytokine derivation models using a combination of factors: stem cell factor
(SCF), GM-CSF, and IL-4. The method using Flt3L alone or combined with SCF
supported the development of pig bone marrow hematopoietic cells into in vivo
equivalent conventional DCs (cDCs). The equivalent cDC1 (the minor population in
the cultures) were characterized as CADM1+CD14−MHC-II+CD172a−/loCD1−CD163−
DEC205+CD11R3loCD11R1+CD33+CD80/86+. They expressed high levels of FLT3,
ZBTB46, XCR1, and IRF8 mRNA, were efficient in endocytosing dextran and in
proliferating allogenic CD4+CD8+ T cells, but were deficient in phagocyting inactivated
Staphylococcus aureus (S. aureus). Also, after poly I:C stimulation, they predominantly
produced IL-12p40a and matured as indicated by the increase of MHC-I, MHC-II, and
CD80/86. The equivalent cDC2 (the main population) were CADM1+CD14−MHC-II+C
D172a+CD1+CD163−/loDEC205loCD11R3+CD11R1+CD33+CD80/86+; meanwhile,
they overexpressed FcεR1α and IRF4 mRNA. They showed high efficiency
in the endocytosis of dextran, but weak in phagocytosing bacteria. They
supported allogenic CD4+CD8−/CD4+CD8+ T cell proliferation and were high
producers of IL-12p40 (upon TLR7 stimulation) and IL-10 (upon TLR7 stimulation).
TLR ligand stimulation also induced their maturation. In addition, a CD14+
population was identified with the phenotype CADM1+CD14+MHC-II+CD172a+
CD1+CD163+DEC205−CD11R3+CD11R1+CD33−/loCD80/86+. They shared some
functional similarities with cDC2 and were distinguishable from macrophages. This
CD14+ population was efficient in phagocyting S. aureus but showed less maturation
upon TLR ligand stimulation than cDC1 or cDC2. The alternative methods of DC
derivation including GM-CSF and/or IL-4 produced mostly CADM1− cells that did
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not fulfill the canonical phenotype of bona fide porcine DCs. Our study provides an
exhaustive characterization of Flt3L-derived DCs with different methods that can help
the in vitro study of the interaction of DCs with porcine-relevant pathogens.
Keywords: Flt3L, cDC1, cDC2, CD14+ DC, pig
INTRODUCTION
Pig farming is an important source of animal protein. As of
January 2020, it was estimated that about 677 million pigs
were raised worldwide and are therefore an important source
of economic income in many countries (1). Additionally, pigs
are epidemiologically important hosts of pathogens that can
affect humans such as the H1N1 “swine flu” pandemic in
2009 (2). Pigs are also models for studying several human
diseases (3) and potential donors for xenotransplantation
(4). In all those aspects, a better understanding of the pig
immune system and of the interaction of pathogens with it is
scientifically relevant.
Dendritic cells (DCs) are sentinels of the immune system,
essential for the activation of naïve T cells to promote the
initiation of the adaptive immune response. Currently, there
are different types of DCs that are recognized based on their
ontogeny (5, 6): the monocyte-derived DCs (moDCs), which
are generated from activated monocytes in the tissues (7), and
the conventional or bona fide DCs that are generated from
Flt3 (CD135)-expressing precursors (8) and can be subdivided
into classical/conventional (c) cDC1 and cDC2, which can be
differentiated by gene expression and cytokine profiles (5, 6)
and their ability to cross-present antigens (9, 10). Additionally,
there are plasmacytoid DCs (pDCs), specialized in producing
high amounts of type I interferons (especially IFN-α) during
antiviral responses (11, 12), and finally, Langerhans cells
are a special type of DCs generated from erythro-myeloid
progenitors (6).
One limitation when studying bona fide DCs in pigs
or other species is the low frequency of these cells. For
example, in pig blood, cDC1, cDC2, and pDC accounted
for only 0.1, 0.1, and 0.5-1%, respectively, of the intact
Peripheral Blood Mononuclear Cells (PBMCs) (13); in lung,
5.6 ± 5.1% and 11.8 ± 12.3% of the MHC-IIhi cells were
identified as potential cDC1 and cDC2, respectively (14); in
lymphoid tissues, 56.9 ± 3.1% and 30.1 ± 8.5% of cells were
identified as cDC1 and cDC2, respectively, among lymphocyte-
depleted MHC-IIhiCADM1hi cells (15). This scarcity makes
it extremely difficult to perform functional analysis or to
investigate DC functionality upon sensing pathogens. Apart
from that, when obtaining DCs from tissues, the extraction
process imposes a series of manipulation that may damage
cell surface receptors or modify cell maturation status, which
subsequently will deviate the DC functionality from in vivo
conditions. Thus, in vitro production of DCs can be a convenient
alternative. A review of the literature shows that, for many
years, production of DCs in pigs was done by stimulating
monocytes with GM-CSF and IL-4 or bone marrow precursors
with GM-CSF (16). While the first method consistently produced
CD163+ moDCs, the second generated a more heterogeneous
population (16).
In human and mice, bona fide DCs are identified as cells
originating from a common macrophage and DC precursor
(MDP), which gives rise to a common DC precursor (CDP),
restricted to develop into cDCs (cDC1 and cDC2), and pDC
(6, 17). Flt3 seems to be a key molecule in DC development. In
mice, Flt3 is broadly expressed on hematopoietic precursors and
exists throughout the whole process of DC development (18)
and during commitment to DCs; the expansion and migration
of precursor cells are essentially Flt3L-dependent processes (8).
In pigs, Guzylack-Piriou et al. (19) showed that addition of
Flt3 ligand (Flt3L) to bone marrow cell cultures produced cells
with features of bona fide DCs. In the past years, DCs from
pig lymphoid (spleen, tonsil, and lymph nodes) (15, 20) and
non-lymphoid organs (skin and lung) (14, 21) as well as blood
(22) have been successfully identified and characterized. From
the abovementioned studies, consensus has been reached on the
phenotype of cDC1 (CADM1+CD14−MHC-II+CD172a−/lo),
cDC2 (CADM1+CD14−MHC-II+CD172a+), and pDC
(CADM1−CD14−CD172a+CD4+). In the present study,
we re-examined the features of pig DCs produced in an
Flt3L-dependent culture model regarding the phenotype, gene
expression, and functionality. Moreover, we compared the use of
FLt3L alone with other cytokine combination [addition of stem
cell factor (SCF), GM-CSF, and IL-4] in order to determine the
effects on the yield and type of DCs produced.
MATERIALS AND METHODS
Obtention of Bone Marrow Cells
Porcine bone marrow hematopoietic cells (BMHCs) were
aseptically obtained from femora and humeri from 4-week-
old pigs as previously described (16). Animals were all
Landrace × Large White and came from the same source
farm. BMHCs were tested by PCR to confirm that they were
free of porcine reproductive and respiratory syndrome virus
(PRRSV; VetMAX PRRSV NA & EU Reagents; Thermo Fisher
Scientific, Spain), porcine circovirus type 2 (PCV2), Mycoplasma
hyopneumoniae, and torque teno sus virus (TTSuV) 1 and 2
(23–25). Cells were frozen in liquid nitrogen until used.
Generation of DCs From
Flt3L-Dependent Bone Marrow Cultures
For DC generation, BMHCs were seeded in 24-well plates at
a density of 1 × 106 cells/600 µl in RPMI 1640 medium
supplemented with 10% fetal calf serum (FCS), 2 mM glutamine,
20 mM HEPES, 100 units/ml penicillin, and 100 µg/ml
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streptomycin. 20 nanograms per milliliter of recombinant human
Flt3L (rhuFlt3L, Fisher Scientific, Spain) was added to promote
expansion and differentiation of Flt3+ or relevant cells. Cells
were incubated for 14 days at 37◦C in a 5% CO2 and 90%
humidity environment. Half of the medium was replaced every
3 days with fresh supplemented medium containing the same
concentration of Flt3L.
To assess the development of DCs, cultures were
examined at regular intervals during the 2-week period of
incubation. For this purpose, BMHCs were labeled with
5 µM CellTrace Violet (Fisher Scientific, Spain), washed,
and seeded at 0.8 × 106 cells/600 µl into the 24-well plates.
Proliferation was assessed at 0, 1.5, 3, 6, 9, 12, and 14 days of
incubation by flow cytometry. Proliferated CADM1+MHC-
II+ cells were considered as potential Flt3L-derived DCs. All
experiments in the present work were done at least in triplicate
except when indicated.
Obtention of Alveolar Macrophages,
Isolation of Peripheral Blood
Mononuclear Cells and Monocytes, and
Generation of Monocyte-Derived DCs
Alveolar Macrophages (AMs) and PBMCs were obtained from
the same pigs as described in “Obtention of Bone Marrow
Cells” through, respectively, broncho-alveolar lavage and density
gradient centrifugation with Histopaque 1.077 (Sigma-Aldrich,
Spain). AMs and PBMCs were frozen in liquid nitrogen until
used. The selected batches had viabilities >90% after thawing as
assessed by trypan blue staining. For PBMCs, the proportion of
each T cell subset and the proliferation capability were also tested
in one sample per batch. Batches passing this quality control
(viability and proliferation capability) were used. Monocytes
were obtained through plastic adherence of PBMCs for 16 h
at 37◦C in 5% CO2 and used freshly. moDCs were generated
by differentiating blood monocytes with recombinant porcine
GM-CSF (rpGM-CSF, 20 ng/ml; R&D Systems, Spain) and rpIL-
4 (20 ng/ml; R&D Systems, Spain) according to the method
described by Carrasco et al. (16).
Flow Cytometry Analysis
Staining of cell surface molecules was performed in PBS with 5%
FCS and 5% horse serum for 30 min on ice. Primary antibodies
(conjugated or not) and their working dilutions are listed in
Table 1. When necessary, secondary antibodies, anti-mouse
IgG1, IgG2a, and IgG2b coupled to Brilliant Violet 421 (BV421),
Alexa Fluor 488, R-phycoerythrin (R-PE), or Alexa Fluor 647,
were used at a dilution of 1:800 to 1:1600. The antibodies included
in the panel were previously titrated to determine the appropriate
dilution. Between each labeling step, cells were washed twice with
PBS containing 2% FCS and centrifuged at 500 × g for 5 min.
Samples were acquired on a MACSQuant Analyzer 10 (Miltenyi
Biotec, Bergisch Gladbach, Germany) or sorted on BD FACSJazz
(BD Biosciences, Oxford, United Kingdom). Fluorescence minus
one (FMO) controls, matched isotype controls for mouse IgG1,
IgG2a, and IgG2b, and background from secondary antibodies
were used for analysis and gating. The acquired data were
analyzed using FCS Express 7 (de novo Software, Glendale,
CA, United States).
For phenotypic characterization of the generated DCs, a five-
color staining was performed for cell surface molecules CADM1,
CD14, MHC-II, and CD172a, plus a fifth marker targeting
CD1/CD163/DEC205/CD11R3/CD11R1/CD33/CD80/86. Anti-
CD11R3 and anti-CD11R1 were used to stain CD11b. These
two antibodies were reported to be specific for CD11b but
with different staining patterns in pigs (26). Cells were initially
incubated with antibody anti-CADM1 followed by anti-chicken
IgY biotin and the primary antibody of the fifth marker. Then,
streptavidin PerCP-Cy5.5 and a secondary antibody coupled to
BV421 were added. Finally, cells were stained with anti-CD14
FITC, anti-MHC-II conjugated to anti-mouse IgG2b Zenon
Alexa Fluor 647 (Thermo Fisher Scientific, Spain), and anti-
CD172a conjugated to LYNX Rapid RPE (Bio-Rad, Spain).
For the combination with CD1, CD172a and CD1 were both
indirectly labeled with secondary antibodies coupled to BV421
and RPE, respectively. CD80/86 was labeled by an antibody
anti-mouse CD80 (B7-1) Super Bright 436.
RNA Extraction and Quantitative
Real-Time PCR
Total RNA from FACS-sorted DC subpopulations was extracted
with TRIzol (Thermo Fisher Scientific, Spain) according to
the manufacturer’s protocol and quantified with a Biodrop
spectrophotometer (BioDrop, United Kingdom). Genomic DNA
was removed using a gDNA removal kit (ArcticZymes, Sweden).
Then, 20 ng was used to amplify mRNA transcripts of FLT3,
ZBTB46, XCR1, BATF3, IRF4, IRF8, FCεR1a, ITGAM (CD11b),
ITGAX (CD11c), CD64, CSF1R, MAFB, MERTK, KLF4, and
MGL2 genes using iTaq universal SYBR green one-step kit (Bio-
Rad, Spain) and the adequate primers (Table 2) in a 7500 Real-
Time PCR System (Applied Biosystems). The same pig origin of
AMs, monocytes, or GM-CSF/IL-4-differentiated moDCs were
included for comparison as needed. Relative levels of mRNA were
assessed according to the 1Ct method and calculated with the
formula 2−1 Ct . Both Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and ribosomal protein 24 (RSP24) were used as
reference genes as previously described (14). No significant
difference was found when applying the normalization to the two
reference genes; thus, the result to GAPDH was shown.
Dextran-FITC Uptake
Sorted DC subpopulations (with 4000 to 6000 cells used in
each test) were incubated with Dextran-FITC (molecular weight
40,000; Sigma-Aldrich, Spain) at 1 mg/ml in complete RPMI 1640
for 2.5 h either at 37◦C or on ice (negative control). Free Dextran-
FITC was washed away, and uptake activity at both temperatures
was determined by flow cytometry. The median fluorescence
intensity (MFI) of cells incubated at 37◦C was compared with the
corresponding cells incubated on ice.
Phagocytosis of Staphylococcus aureus
Sorted DC subpopulations (10,000 cells in each test) were
incubated with Alexa 488-labeled S. aureus (Thermo Fisher
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TABLE 1 | Antibodies used for flow cytometry analysis.
Antibody Clone Isotype Species produced Working dilution Supplier
Anti-CD14 FITC conjugated MIL2 IgG2b Mouse 1/100 Bio-Rad
Anti-CD172a BL1H7 IgG1 Mouse 1/500
Anti-SLA II DR 2E9/13 IgG2b Mouse 1/500
Anti-CD11R1 MIL4 IgG1 Mouse 1/500
Anti-CD11R3 2F4/11 IgG1 Mouse 1/500
Anti-CD1 76-7-4 IgG2a Mouse 1/50
Anti-CD163 2A10/11 IgG1 Mouse 1/250
Anti-CD3 PPT3 IgG1 Mouse 1/200
Anti-CD4a FITC conjugated 74-12-4 IgG2b Mouse 1/200 BD Pharmingen
Anti-CD8a Alexa Fluor 647 conjugated 76-2-11 IgG2a Mouse 1/100
Anti-human CADM1 3E1 IgY Chicken 1/1000 MBL
Anti-mouse CD80 (B7-1) Super Bright 436 conjugated 16-10A1 IgG2a Armenian hamster 1/150 eBioscience
human CD152 (CTLA-4)-muIg fusion protein – IgG2a Mouse 1/50 Ancell
Anti-DEC-205 (hybridoma supernatant) 9HZF7 IgG1 Mouse 1/1 Provided by Lab. de Inmunología, CIAD, A.C.
Anti-CD33 (Siglec-3) (hybridoma supernatant) 5D5 IgG1 Mouse 1/1 Gift from Dr. J. Domiìnguez*
Anti-MHC-I (hybridoma supernatant) 4B7/8 IgG2a Mouse 1/1
*Department of Biotechnology, INIA, Madrid, Spain. Antibodies without specific indications are anti-pig antibodies.
Scientific, Spain) at 20 µg/ml (equivalent to a ratio of 60 particles
per cell) in complete RPMI 1640 for 1 h either at 37◦C or
on ice (negative control). Extracellular bound S. aureus were
quenched by addition of 1 mg/ml trypan blue before the analysis
by flow cytometry.
Mixed Lymphocyte Reaction Assay
To test antigenic presentation capabilities of each DC
subpopulation, allogeneic PBMCs were used as a source of
responder cells. These PBMCs were obtained from 12-week-old
pigs (free of PRRSV, PCV2, Mycoplasmas, TTSuV 1 and 2, and
influenza A) and then frozen and tested as described above.
Then, they were labeled with CellTrace Violet (Fisher Scientific,
Spain) and re-suspended in medium containing 10% FCS at
1× 106 cells/ml with 100 µl/well plated in the 96-well U-bottom
plate. The sorted DC subpopulations (cDC1, cDC2, and CD14+
DCs) were added as stimulators at a ratio of 1:5 based on the
number of allogeneic PBMCs. After 5 days of culture, cells
were harvested and stained with anti-CD3, anti-CD4, and
anti-CD8a antibodies (see Table 1 for details) before the flow
cytometry analysis. PBMCs without DCs added were used
as the negative control; AMs and monocytes (the same pig
origin as the sorted DCs) were obtained as described above and
used as other cell-type references. Results were reported as in
previous studies (14) using a relative proliferation index where
a value of 1 was assigned to the cell population producing the
highest percentage of proliferating cells; all other subsets were
normalized to it.
Response to TLR Agonist Stimulation:
Maturation Markers and Cytokine
Patterns
Sorted DC subpopulations (cDC1, cDC2, and CD14+ DCs)
were re-suspended at a density of 250,000 cells/ml with medium
containing 10% FCS and were then seeded in 96-well U-bottom
plates (200 µl/well, equivalent as 50,000 cells/well) in the
presence of TLR agonists: 10 µg/ml poly I:C, 1 µg/ml LPS,
or 10 µg/ml gardiquimod (all from InVivogen, reconstituted
according to the manufacturer’s instructions). In parallel, control
cells were cultured without the TLR agonists, and AMs were
included as other cell-type reference. After 18 h of incubation,
cells were stained for MHC-I, MHC-II, and CD80/86. For
CD80/86 staining, human CD152 (CTLA-4)-muIg (Ancell,
Bayport, MN, United States), which binds to CD80/86, was
used (see Table 1). Supernatants were harvested and frozen at
−80◦C until used.
Presence of IFN-α, IFN-γ, IL-4, IL-6, IL-12p40, IL-10, IL-
1β, TNF-α, and IL-8 (CXCL8) in the cell culture supernatants
was measured by means of the Porcine ProcartaPlex Multiplex
Immunoassay (Labclinics, Spain) according to the manufacturer’s
instructions. Briefly, 50 µl of each sample was added to
a well of a 96-well plate containing fluorescent antibody-
coated beads. After overnight incubation, 25 µl of biotinylated
detection antibodies followed by 50 µl of streptavidin-PE
antibodies were added. Finally, beads in each well were re-
suspended with 120 µl of assay buffer and analyzed by a
MAGPIX system. Concentration of cytokines in each sample
was determined by using standard curves, which were fitted by
a four-parameter logistic regression model. All samples were
run in duplicate.
Effect of SCF, GM-CSF, and IL-4 Addition
to Flt3L-Based BMHC Cultures
In subsequent experiments, additional cytokines that regulate
DC lineage commitment and differentiation were added to
compare with the use of Flt3L alone. SCF (Kingfisher Biotech,
Spain) was added to test its effect on the expansion and
survival of progenitor cells, which afterward was combined with
the addition of GM-CSF (20 ng/ml; R&D Systems, Spain) or
IL-4 (20 ng/ml; R&D Systems, Spain). The combination of
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TABLE 2 | Primers used for RT-qPCR.
















ITGAM (CD11b) F: AGAAGGAGACACCCAGAGCA
R: GTAGGACAATGGGCGTCACT
397459 197 (56)




































cytokine cocktails included the following: (1) Flt3L (as standard
method), (2) Flt3L + SCF, (3) Flt3L + SCF + GM-CSF (FSG),
and (4) Flt3L + SCF + GM-CSF + IL-4 (FSG4). In cases
(3) and (4), a two-step protocol was used. In the first step,
BMHCs were cultured in the presence of Flt3L (either 20
or 100 ng/ml) and SCF (either 20 or 100 ng/ml) to expand
progenitors. After 6 days of culture with one medium changed
at day 3, cells were re-plated in cultures containing cytokine
cocktails Flt3L + SCF + GM-CSF (FSG) or Flt3L + SCF + GM-
CSF + IL-4 (FSG4) to induce further cell differentiation. Cells
were kept for an additional 12-day period (18-day period
in total) with cocktail replenishment after 6 days. All the
cases were phenotypically analyzed by a four-color staining of
CADM1, CD14, MHC-II, and CD172a as described under “flow
cytometry analysis.”
Statistical Analysis
All data were analyzed using the GraphPad Prism 8.0 software
package (GraphPad Software, La Jolla, CA, United States).
Statistical tests applied to each data set are indicated in the
relevant figure legend.
RESULTS
Three Distinct Cell Populations Can Be
Identified in Flt3L-Derived Bone Marrow
Cell Cultures
After 2 weeks of culture, stimulation of BMHCs with
Flt3L resulted in the development of a large subset of cells
expressing CADM1 (59.5 ± 12.9%), among cells after gating
singlets and excluding cell debris as shown in Figure 1A.
Among those CADM1+ cells, three subpopulations could
be identified based on the cell surface expression of CD14,
MHC-II, and CD172a. The major one (52.9 ± 4.0%,
among cells of CADM1+) presented a phenotype of
CD14−MHC-IIhiCD172a+ that was compatible with cDC2.
The second population was CD14−MHC-IIhiCD172a−/lo,
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FIGURE 1 | Phenotype of Flt3 ligand-derived dendritic cells (Flt3L-DCs). Cells were stained for multi-color flow cytometry. (A) Illustrative density plots show the
gating strategy: singlets→ excluding cell debris→ selecting CADM1+ population and divided by CD14→ identify cDC1-putative and cDC2-putative populations
based on MHC-II+ and different expression of cD172a. Three putative populations were identified with cDC1-putative population gated as
CADM1+CD14-MHC-II+CD172a-/lo, cDC2-putative population as CADM1+CD14-MHC-II+CD172a+, and plus a CD14+ population
(CADM1+CD14+MHC-II+CD172a+) without classification. (B) Expression of phenotypic markers CD1, CD163, DEC205, CD11R1, CD11R3, CD33, and CD80/86
on the defined cDC1-putative, cDC1-putative, and CD14+ populations was assessed by flow cytometry. The filled histogram represents the FMO control. The
density plots and histograms shown are illustrative for one but represent four pigs.
which represented only 4.7 ± 1.6% of the CADM1+
cells and was compatible with cDC1. Finally, a third
population with phenotype CD14+MHC-II+CD172a+
accounted for 39.6 ± 3.8% of the CADM1+ cells. No
CD4+ cells (not shown) were detected, indicating that
pDCs were probably not present in the Flt3L-derived
cultures or in a very low proportion. Further phenotypical
characterization (Figure 1B) showed that putative cDC2
were predominantly CD1+, CD163lo, DEC205lo, CD11R3+,
CD11R1+, CD33+, and CD80/86+, while putative cDC1
were CD1−, CD163−, DEC205+, CD11R3lo, CD11R1+,
CD33+, and CD80/86+. The CD14+ subset was predominantly
CD1+, CD163+, DEC205−, CD11R3+, CD11R1+, CD33−/lo,
and CD80/86+. The latter subset (CD14+) phenotypically
resembled moDCs but could not be classified with absolute
certitude due to the high expression of CADM1 (16).
They will be designated as CD14+ DCs for the purpose of
the present paper.
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FIGURE 2 | Development of Flt3-ligand-derived dendritic cells (Flt3L-DCs) during a 14-day culture period. (A) Bone marrow hematopoietic cells (BMHCs) were
labeled with CellTrace Violet before stimulation with Flt3L. Cells were collected on days 1.5, 3, 6, 9, 12, and 14 and stained with antibodies anti-MHC-II and
anti-CADM1. Proliferating cells (Violetlo) with a MHC-II+CADM1+ phenotype were considered as potential DCs. The gating strategy was MHC-II+CADM1+Violetlo.
(B) Total number of viable cells in the culture versus time of incubation (black line), and proportion of potential DCs among viable cells versus time (orange line).
Results were obtained with cells from three pigs. Average and standard deviation of the proportion of potential DCs are shown.
Development Process of Flt3L-Derived
Bone Marrow Cell Cultures
Next, we examined the development of CADM1+ and MHC-II+
cells in Flt3L-stimulated bone marrow cultures during the 14-day
period (Figure 2). At day 0, no CADM1+ cells were detected
in BMHC while MHC-II+ cells accounted for 16.0 ± 1.2% of
the viable cells (data not shown). After 1.5 days of incubation,
the number of viable cells dropped sharply (62.5 ± 3.5% of
reduction; Figure 2B, black curve), suggesting that most of non-
Flt3L-primed progenitors and other non-precursor cells died
during this time. From that day on, CADM1+MHC-II+ cells
started to develop. By day 6, an explosive increase of MHC-
II+ cells was observed (35.5 ± 7.9% of total cells), among
which 53.0 ± 4.2% were CADM1+Violetlo (Figure 2A). This
trend continued by day 12 with MHC-II+ reaching 56.3 ± 1.1%
and CADM1+Violetlo increasing to 76.3 ± 9.2% among MHC-
II+ cells. A small decrease in the proportion of CADM1+
was observed by day 14 (Figure 2A). The development of
CADM1+MHC-II+ cells determined the potential DCs among
all viable cells that boosted at day 6 (19.0 ± 5.7% of viable cells)
until day 12 (42.9 ± 4.3%) and finally declined slightly to 36.4%
(Figure 2B, orange curve).
Expression of Conserved DC Markers
Assessed by RT-qPCR
To assess the expression of relevant canonical genes for the
identification of DCs, the putative cDC1, cDC2, and CD14+
DC populations were sorted as indicated in Figure 1A, and M8
were used for comparison. As shown in Figure 3, putative cDC1,
cDC2, and CD14+ DCs expressed FLT3, with cDC1 showing
the highest expression followed by cDC2 and CD14+ DCs; the
same expression pattern occurred on ZBTB46, a transcription
factor used to distinguish cDCs from other immune lineages
in mice (27). Beyond that, putative cDC1 exclusively expressed
XCR1 and IRF8; the assumed cDC2 overexpressed FcεR1a and
IRF4, while CD14+ DCs showed low or intermediate levels of
these genes. All three subsets expressed ITGAM. By contrast,
AMs scarcely expressed these genes (FLT3, ZBTB46, XCR1, IRF8,
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FIGURE 3 | mRNA expression levels of FLT3, ZBTB46, XCR1, IRF8, FcεR1a, IRF4, ITGAM, ITGAX, and CD64 in sorted putative cDC1, cDC2, and CD14+ DCs were
assessed by quantitative Real-Time PCR (RT-qPCR). Alveolar macrophages (AMs) were used as a different cell-type reference. For each gene, data were normalized
to the expression of the reference gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and shown as relative value [arbitrary units (AUs)]. For each animal,
the cell population with the highest expression for each gene was considered as 1.0 and the other populations were normalized to it. Each symbol represents one
animal; median is shown for each data set. Statistical significance was calculated by the Kruskal–Wallis test with multiple comparisons performed by
Dwass–Steel–Critchlow–Fligner. Significant difference was indicated with different letters a, b, c, . . . ; no letters were shown if no significance was found between
groups.
FcεR1a, IRF4, and ITGAM), but overexpressed CD64 as expected.
ITGAX (CD11c) was highly expressed on macrophages as well,
but lower on the putative cDC1, cDC2, and CD14+ DCs. This
is contrary to the result of pig blood cDCs (22) but somewhat
consistent with the analysis of lung DCs (28).
To further characterize the CD14+ subset, we assessed the
expression of MAFB, CSF1R, MERTK, KLF4, and MLG2 on
this cell population and compared them with cDC1, cDC2,
monocytes, GM-CSF/IL-4 differentiated moDCs, and AMs. As
shown in Figure 4, CD14+ DCs highly expressed CSF1R and
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FIGURE 4 | mRNA expression levels of CSF1R, MAFB, MERTK, KLF4, and MGL2 in sorted putative cDC1, cDC2, and CD14+ DCs were assessed by quantitative
Real-Time PCR (RT-qPCR). Monocyte-derived DCs (moDCs), monocytes, and alveolar macrophages (AMs) were used as cell-type references. For each gene, data
were normalized to the expression of the reference gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and shown as relative value [arbitrary units (AUs)].
For each animal, the cell population with the highest expression for each gene was considered as 1.0, and the other populations were normalized to it. Each symbol
represents one animal, median is shown for each data set. Statistical significance was calculated by the Kruskal–Wallis test with multiple comparisons performed by
Dwass–Steel–Critchlow–Fligner. Significant difference was indicated with different letters a, b, c, . . . ; no letters were shown if no significance was found between
groups.
MAFB and expressed MERTK at an intermediate level. They also
expressed KLF4 but not MGL2.
Functional Analysis of Putative cDC1,
cDC2, and CD14+ DCs
Two of the main properties of DCs are their capacities to
capture antigens and then present them to activate naïve T cells.
Thus, we tested the endocytic and phagocytic capabilities of the
putative cDC1, cDC2, and CD14+ DCs. Dextran-FITC uptake
and S. aureus phagocytosis experiments were set up for that
purpose. All three populations presented an efficient uptake of
dextran-FITC, with cDC1 and cDC2 showing higher capabilities
than CD14+ DCs (Figure 5A). Of note, the histogram of cDC1
showed a bimodal distribution with two distinct subsets based
on their uptake (high and moderate, Figure 5A). Although
cDC1 contained cells of CD172a− and CD172alo, the two
subsets with distinct uptake capabilities were not correlated
with this molecule (Supplementary Figure 1) or with MHC-
II (Supplementary Figure 1). cDC2 and CD14+ DCs showed
a unimodal distribution. With regard to the phagocytosis of
S. aureus, only a small fraction of cDC1 (0.9 ± 0.2%) and
cDC2 (1.5 ± 1.8%) were phagocytic (Figure 5B); in contrast,
CD14+ DCs showed a clear phagocytic activity (15.6 ± 7.2% of
positive cells).
Next, we examined whether putative cDC1, cDC2, and
CD14+ DCs possessed the capacity to activate allogeneic T cells
in a mixed lymphocyte reaction (Figure 5C). The three DC
populations did not show any significant difference in inducing
CD4 or CD8 T cell proliferation. Of note, both the putative cDC1
and cDC2 were more efficient than CD14+ DCs or macrophages
in inducing the proliferation of CD4+CD8+ T cells, with cDC1
being the most efficient type, although no significant difference
was shown. Interestingly, cDC1 and cDC2 were less efficient in
inducing proliferation of CD4−CD8− T cells.
Response to TLR Agonist Stimulation:
Maturation Markers and Cytokine
Patterns
Response of each DC subpopulation to TLR3, TLR4, and TLR7
ligands was assessed by determining the expression of MHC-
I, MHC-II, and CD80/86 (Figure 6), and the cytokine profiles
(Figure 7) after stimulation with poly I:C, LPS, and gardiquimod,
respectively. The results showed that in cDC1, MHC-I, MHC-
II, and CD80/86 were highly increased when stimulated by poly
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FIGURE 5 | Assessment of antigen uptake and antigen presentation capabilities of putative cDC1, cDC2, and CD14+ DCs. (A) Endocytic capability of different DC
populations was evaluated by incubating cells with dextran-FITC for 2.5 h either at 37◦C or on ice with FITC fluorescence assessed by flow cytometry. Results are
depicted as Mmedian fluorescence intensity (1MFI) by subtracting MFI of cells incubated on ice from MFI of cells incubated at 37◦C (data are the means of two pigs
with each animal tested in triplicate). Overlapped histograms showed the fluorescence intensity of cells incubated at 37◦C (open histograms) and cells incubated on
ice (closed histograms). (B) Phagocytic activity of different DC populations was evaluated by incubating cells with Alexa 488-labeled inactivated S. aureus for 1 h
either at 37◦C or on ice and analyzed by flow cytometry. Results are depicted as cells positive for S. aureus (data are the means of four pigs with each animal tested
in triplicate). Overlapped histograms showed the fluorescence intensity of cells incubated at 37◦C (open histograms) and cells incubated on ice (closed histograms).
(C) Sorted DCs (putative cDC1, cDC2, and CD14+ DC) and PBMCs (stained with CellTrace Violet) from allogeneic pigs were mixed at an APC:T cell ratio of 1:5
before being cultured for 5 days at 37◦C. Alveolar macrophages (AMs) and monocytes were used as other cell-type references. Proliferation of CD4+CD8α-,
CD4-CD8α+, CD4+CD8α+, and CD4-CD8α- was assessed by CellTrace Violet dilution (see Supplementary Figure 2 for gating strategy). Each symbol
corresponds to one type of DC reacting with one batch of PBMCs. The median is shown for each data set (horizontal bar). For each animal, the highest proliferation
value was considered as 1.0, and the other populations were normalized to it. Data are from three independent experiments and a minimum of two animals for each
cell type. Statistical significance was calculated by the Kruskal-Wallis test with multiple comparisons performed by Dwass-Steel-Critchlow-Fligner. ***p < 0.001,
**p < 0.01, and *p < 0.05.
I:C or gardiquimod. Nevertheless, the cell viability was largely
damaged by using gardiquimod or LPS, but not by poly I:C.
In cDC2, MHC-I, MHC-II, and CD80/86 were increased by the
addition of any of the three TLR ligands, but LPS was less effective
in increasing MHC-I or CD80/86. On the contrary, CD14+ DCs
had only a slight increase of MHC-I, but not MHC-II or CD80/86
when stimulated.
Regarding the cytokine patterns (Figure 7), no cytokines were
boosted by LPS or gardiquimod in cDC1. IFN-α (<40 pg/ml),
IFN-γ (<5 pg/ml), or IL-4 (<5 pg/ml) were rarely detected in
any DC subset supernatant regardless of the TLR agonists used
(data not shown).
Beyond that, the putative cDC1 produced substantial amounts
of IL-12p40 (3284 ± 4429 pg/ml) when stimulated by poly
Frontiers in Immunology | www.frontiersin.org 10 October 2020 | Volume 11 | Article 553859
fimmu-11-553859 October 8, 2020 Time: 12:3 # 11
Li et al. Flt3L-Derived Pig Conventional DC
FIGURE 6 | Expression of MHC-I, MHC-II, and CD80/86 on putative cDC1, cDC2, and CD14+ DCs after stimulation by TLR3, TLR4, and TLR7 agonists (10 µg/ml
poly I:C, 1 µg/ml LPS, and 10 µg/ml gardiquimod, respectively) for 18 h or unstimulated as controls. Unstimulated control, gray histogram; poly I:C, red histogram;
LPS, blue histogram; gardiquimod, green histogram. Data are representative of three pigs.
I:C. Putative cDC2 and CD14+ DCs only produced IL12p40
in cells stimulated with gardiquimod (4292 ± 4599 pg/ml and
1218 ± 1686 pg/ml, respectively; Figure 7). AMs did not
produce this cytokine.
With respect to IL-10, only putative cDC2 and CD14+ DCs
produced this cytokine with CD14+ DCs making larger amount
following the stimulation by gardiquimod (1083 ± 996.4 pg/ml)
or poly I:C (666 ± 722 pg/ml), while cDC2 produced an
intermediate amount (485 ± 509 pg/ml) in response to
gardiquimod (Figure 7).
Regarding the pro-inflammatory cytokines (IL-1β and TNF-
α), none was detected in the supernatant of cDC1 regardless of
the TLR agonist used. In contrast, moderate amounts of IL-1β
was detected in the supernatant of cDC2 (299 ± 277 pg/ml)
or CD14+ DCs (215 ± 184 pg/ml) in both cases, through
the TLR7-signaling pathway. Notably, while negligible TNF-
α was produced by cDC2 or CD14+ DCs, AMs produced
a considerable amount, regardless of the TLR ligand used
(19,814 ± 6655 pg/ml with poly I:C; 11,514 ± 3305 pg/ml with
LPS; and 12,984± 5169 pg/ml with gardiquimod; Figure 7).
In addition, a tiny amount of IL-6 was produced by cDC2
(20.5 ± 19.7 pg/ml) and CD14+ DCs (17.1 ± 22.0 pg/ml) upon
gardiquimod treatment. IL-8 (CXCL8), an essential chemokine
secreted from DCs involved in both Th1 and Th2 responses, was
highly secreted by cDC2, CD14+ DCs, or AMs. It is noteworthy
that there was a decrease in cDC2 cytokine secretion when these
cells were stimulated by poly I:C, indicating that there might be
an inhibition of IL-8 secretion by the activation of TLR3 signaling
pathway. cDC1 did not produce this cytokine (Figure 7).
Addition of SCF, GM-CSF, or IL-4 Does
Not Improve the Production of cDCs
Once the cell populations originated after Flt3L stimulation were
identified and characterized, we tried to optimize the production
of DCs. Firstly, we compared the use of 20 ng/ml versus
100 ng/ml. This had no evident effect on the phenotype, the yield,
or the relative proportions of different DC populations within the
Flt3L-derived bone marrow cell cultures (not shown). Secondly,
SCF was added to Flt3L-stimulated cultures at 20 ng/ml. The only
noticeable effect was an increase in the yield of DC-compatible
cells at the end of the 14-day incubation period that, on average,
was 24% with no significant change in the type of cells produced
or their relative proportions. Increase of SCF to 100 ng/ml did not
show significant changes.
In the next step, GM-CSF was added to the bone marrow
cultures after 6 days of the expansion of Flt3+ precursors,
culturing for an extra 12 days (18-day period in total). The
resulting cells on day 12 contained mostly (around 90%)
CADM1−CD14+CD172a+, among which 30% were MHC-
II+. These CD14+CD172a+ cells were further characterized
as CD1−CD163+DEC205+. Nevertheless, by day 18, around
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FIGURE 7 | Continued
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FIGURE 7 | Cytokine production by sorted DC subsets (putative cDC1, cDC2, and CD14+ DCs) following TLR stimulation. Cells were stimulated for 18 h with
10 µg/ml poly I:C, 1 µg/ml LPS, 10 µg/ml gardiquimod, or left unstimulated as controls. The supernatants were harvested and tested for IFN-α, IFN-γ, IL-4, IL-6,
IL-12p40, IL-10, IL-1β, TNF-α, and IL-8 (CXCL8) by multiplex immunoassay. Production of IL-12p40, IL-10, IL-1β, TNF-α, IL-6, and IL-8 (CXCL8) was shown, while
IFN-α, IFN-γ, or IL-4 were not shown as rarely detected. Alveolar macrophages (AMs) were used as a different cell-type reference. The values were displayed with
logarithmic y-axis. Symbols in different colors represent different animals. The median is shown for each data set.
90% of CD163+ cells transformed to CD163−. Increasing of
Flt3L up to 100 ng/ml did not substantially modify this profile
(Supplementary Figure 3).
With the same scenario, addition of IL-4 produced mostly
CADM1−CD14+CD172a+ cells with MHC-II+ increasing
from 15% on day 12 to 30% by day 18. However, in this
case, the CD14+CD172a+ population could be further
subdivided based on the expression of CD1 (roughly a
ratio of 1:0.8 of CD1+/CD1−) and CD163 (roughly a ratio
of 1:1.5 of CD163+/CD163−). Only a small proportion
of the CADM1−CD14+CD172a+ expressed DEC205
(Supplementary Figure 3).
DISCUSSION
The study of DCs and their interactions with pathogens is one
of the main areas of research in immunology. One obstacle for
these studies is the low proportion of DCs residing in tissues,
which makes it difficult to obtain sufficient cell number for
further analysis. Establishing an in vitro DC derivation model can
make it more accessible for research i.e. the interaction of DCs
with pathogens, the preliminary screening or testing hypotheses
without need to perform costly whole-animal challenges. Here,
we present a comprehensive characterization of cells produced in
an Flt3L-based in vitro derivation method.
The use of Flt3L alone to stimulate BMHCs produced
three main populations, which shared a CADM1+MHC-II+
phenotype and a variable expression of CD14 and CD172a.
The first population was CADM1+CD14−MHC-II+CD172a−/lo,
which presented full characteristics of cDC1: (1) it was further
phenotyped as CD1−, CD163−, CD11R3lo, CD11R1+, and
DEC205+, equal to the cDC1 described in porcine lymphoid
tissues (15, 20), skin (21), lung (14), and blood (22). Of note,
CD11b was positive on our cDC1, as revealed by the staining
of CD11R3 and CD11R1 and the Quantitative Real-Time PCR
(RT-qPCR) of ITGAM. This was compatible with the expression
pattern of CD11b on blood cDC1 (22) but in contrast with the
findings for lung cDC1 (14). In mice, CD11b is considered a
specific marker of cDC2 (29); in pigs, according to the current
result, CD11b expression on cDCs may depend on the cell
type, as well as on the location of the cells, namely, blood or
tissues; (2) in addition to FLT3 and ZBTB46, these cells highly
expressed XCR1, which is a factor strictly associated with cDC1
(30) as well as IRF8, a driving factor of cDC1 development in
human and mice (31); (3) they showed antigen presentation
capability, particularly in activating allogenic CD8+CD4+ T cells,
indicating the potential of inducing CD8+ effector/memory T
cells; (4) they secreted a substantial amount of IL-12p40 following
poly I:C stimulation, similarly to what was found in tonsil
cDC1 (20) and, in lung cDC1 after influenza A virus infection
(14). However, this differed from blood cDC1 where no IL-
12p40 was detected by multiplex cytokine assay or qRT-PCR.
It is worth noting that stimulation with poly I:C increased the
viability of cDC1 in comparison to using other TLR ligands or
just plain medium. Since poly I:C was a potent inducer of IL-
12p40 in cDC1, it is tempting to speculate that this cytokine
was the cause of the enhanced survival. Poor viability of cDC1
(32) and protection from cell death of cDC1 by IL-12 were
previously reported (33, 34); (5) they were unresponsive to LPS
or gardiquimod, compatible with the negligible expression of
TLR4 and TRL7 on blood cDC1 (22); (6) they were incapable
of producing IL-1β, same as human blood cDC1 where the
scarcely expressed caspase-1 was reasoned (35); (7) they showed
high endocytic capability. Interestingly, two subsets of cDC1
were identified in the dextran uptake experiments: low and
high uptake, which did not correlate with CD172a or MHC-
II expression levels; and (8) they showed very weak phagocytic
activity, comparably to cDC2, but contrasting with the more
efficient CD14+ DCs. This is in agreement with the finding
in mice that the clearance of bulk particles was mostly by
macrophages rather than cDCs (36). With respect to the yield,
this population was the minor one in the Flt3L-derived cells,
accounting for less than 5%. This fact suggests that either the
precursors of cDC1 are scarce or the expansion of precursors
and the survival of generated cDC1 require synergizing efforts
from more factors. In human in vitro production models, cDC1 is
also a minor population compared to cDC2 (17), which contrasts
with the more balanced proportion of cDC1 and cDC2 in mice
models (37).
The second, a major population, had a phenotype of
CADM1+/CD14−/MHC-II+/CD172a+, representative of cDC2
(52% on average among CADM1+ cells). This population
expressed a high level of FcεR1α, which has been identified
as an overexpressed factor on cDC2 in human and pig tissues
(14, 22, 38). IRF4, a driving factor of cDC2 differentiation
(39), was also highly expressed. Combined with additional
phenotypic markers CD1+, CD163lo, CD11R3+, and CD11R1+,
this population was assigned to cDC2. However, the level of
DEC205 on this population was lower than on the putative
cDC1, which might be explained by our previous work in
which expression of DEC205 was variable in cDCs obtained
from different lymphoid tissues (15). When we extended the
culture of these cDC2 for an additional 48 h, more cells
gained DEC205 expression but lost CADM1 (data not shown),
indicating that the lack of DEC205 expression might correspond
to a relatively immature developmental stage. More interestingly,
in our hands, the addition of different cytokines also had an
impact on DEC205 expression. For example, addition of GM-
CSF induced higher expression of DEC205. In other models,
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i.e., human DCs obtained ex vivo from skin, a similar variable
pattern was observed for CD1a+ DDC (40). Furthermore,
from a functional perspective, the putative cDC2 were weak
in phagocytosing killed S. aureus, but efficient in endocytosing
dextran, and were able to induce allogenic T cell proliferation.
They produced IL-12p40 after TLR7 stimulation, which differed
from cDC1 upon TLR3 stimulation. The secretion of IL-12p40
was not the specialty of one DC subtype in our model; this
is contrary with what is reported in human (cDC2) (41) and
mice (cDC1) (42). Moreover, the putative cDC2 were efficient
in producing IL-10 or IL-1β, but not TNF-α, as was described
in human cDC2 (43, 44). Another thing worth mentioning
is the secretion of IL-6. Although it was a small amount
(20.5 ± 19.7 pg/ml), it has been reported that, in mice, low
amounts of IL-6 in the milieu can be trans-presented by the
CD11b+Sirpα+ DCs to initiate the transcriptional program
and generate pathogenic Th17 cells (45). Thus, the cDC2
produced in our study might play a guiding role in Th17 cell
differentiation through secreting IL-6 in pigs. CD33 (Siglec-
3) was positive on both cDC1 and cDC2, consistent with the
study on human in which CD33 has a pan-distribution on
myeloid pre-cDCs and cDCs (44). This is the first report of this
molecule on pig DCs.
The third identified population was CADM1+CD14+MHC-
II+CD172a+ (accounting for roughly 40% of the CADM1+
cells), designated as CD14+ DCs in this paper. It was
further phenotyped as CD1+, CD163+, CD11R3+, CD11R1+,
DEC205−, and CD33−. Based on the expression of FLT3,
ZBTB46, FcεR1a, and IRF4 although low, they could be classified
as cDCs. Furthermore, this CD14+ subset shared functional
similarities with cDC2 in regard to T cell proliferation and
cytokine production in response to TLR stimulation (secretion
of IL-12p40, IL-10, and IL-6 upon gardiquimod treatment
and very low or no TNF-α secretion following poly I:C
or gardiquimod stimulation). This is in concordance with
what was observed in CD14+ DCs in human interstitial
dermis (46, 47). However, the relatively high expression of
CSF1R, MAFB, and, to a lesser extent, MERTK would point
these CD14+ cells toward a myelomonocytic origin. The
CD14+ cells were also the ones with the highest phagocytic
activity and were less responsive to TLR ligands in terms
of maturation, elements favoring the monomyelocytic origin
hypothesis. Nevertheless, moDC differentiation is boosted
by GM-CSF rather than Flt3L (48, 49). Actually, in the
present study, addition of GM-CSF radically changed the
profile of cells obtained. Taken together, and considering
that CADM1 is a cross-species, evolutionarily-conserved DC-
specific marker that is not present in moDCs (38, 39),
classification of the CD14+ subset as cDCs or moDCs
cannot be entirely precise. In the work of Soldevila et al.
(20), a similar CD14+ subset was also identified in porcine
tonsils, which displayed an intermediate attribute between
cDCs and moDCs in terms of phenotype, transcriptomics,
and pathogen clearance. To note, morphologically cDC2
were produced as clusters of 5–15 cells, while CD14+
cells were seen as single cells, but both possessed typical
DC dendritic and veiled extensions and lack of plastic
adherence (data not shown). Other alternative hypotheses
can also be formulated. The CD14+ cells might represent a
subtype of cDC2, originated from the same precursors, but
diversified into a distinct cDC2 subtype dependent on variable
transcription clusters; even they could be in the transitional
stage to cDC2. The presence of IRF4 and ZBTB46, and
the comparable expression of KLF4 was in line with the
two hypotheses.
CD4+ pDCs were not consistently detected in the cultures of
our study, indicating that no or very few pDCs were present.
According to Guzylack-Piriou et al. (19), less than 1% of Flt3L-
stimulated cultures were compatible with pDC. This might be
due to the lack of stromal cells in the culturing system (50), since
their presence has proved to be indispensable for human pDC
derivation in vitro (17).
The kinetic development of Flt3L-derived cells showed a
sharp drop in cell numbers during the first days of incubation,
suggesting death of non-stimulated Flt3− cells in the culture;
meanwhile, the proportion of MHC-II+ cells increased and
afterward the CADM1+ population appeared and expanded.
Based on this kinetic, we attempted to increase the yield of
DCs by introducing SCF to induce hematopoietic progenitor
expansion and subsequent survival (51). Although this resulted
in a 24% increase in yield, the profile of cells produced
was not affected. In contrast, the addition of GM-CSF at
day 6 of incubation resulted in a proportion of CD14+
cells exceeding 90%, in agreement with what was previously
observed in GM-CSF-derived bone marrow cultures (16, 19).
Moreover, the produced cells were mostly CADM1−. These
facts indicate that addition of GM-CSF may produce a
different pattern of cDCs. In human cultures, omission of
GM-CSF results in very low expression of DNGR-1+BDCA3+
DCs (cDC1 equivalent) (52), but in mice cultures, the lack
of GM-CSF or its receptor did not result in a critical
impairment (53). Another noticeable difference between several
cytokine combinations is the expression of CD1. Most of
the cells produced by Flt3L plus GM-CSF stimulation were
CD1−. CD1 expression was restored by addition of IL-4. The
combination of four factors (Flt3L, SCF, GM-CSF, and plus
IL-4) generated a major population (>90%) with phenotype
of CADM1−CD14+CD172a+, and a minor one (<10%) of
CADM1−CD14−CD172a+. These cells were heterogeneous
for CD1 and CD163 expression, with CD163 exclusively
expressed by CD14+ cells (data not shown). Within CD1+
compartment, the CD14−CD163− and CD14+CD163+ subsets
may be analogous to, respectively, cDC2 and the recently
identified human DC3 (54, 55). In our case, CD1 expression
in Flt3L-stimulated BMHCs had a similar expansion kinetic
to CADM1. The reasons why IL-4 restored that expression
are not known yet.
Overall, the Flt3L-based in vitro derivation model produced
in vivo equivalent cDC1 and cDC2 as well as a CD14+ population
that, at present, cannot be precisely classified. This can be a
suitable model to study the ontogeny of pig DCs, to assess
potential functions of pig DCs as well as to study the interaction
of DCs with porcine-related pathogens. The latter application
permits in vitro examination of DCs in responding to pathogens
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without performing animal challenges, complying with the
ethical obligation of reducing animal use in experimentation.
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